Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 7Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Breast Neoplasms 3Leukoplakia, Oral 2Erythroplasia 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urothelial Cancer 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Prediabetic State 1Posterior Fossa Ependymal Tumor 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Obesity 1Neoplasms by Site 1Mouth Neoplasms 1Metabolic Diseases 1Melanoma 1Medulloblastoma 1Insulin Resistance 1Infertility 1Hyperplasia 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Drug-drug Interaction,SHR3680 1

Interventions

Rosuvastatin Calcium 1Metformin 1Digoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-drug Interaction,SHR3680 × Metformin × 90 days × Clear all
NCT04621669 2026-06-05

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
36 enrolled

Drug-drug Interaction,SHR3680

Data powered by HemOnc (CC BY 4.0) Colophon âš¡